COVID-19 has defined the start of a new phase for biopharmaceuticals and their related aspects in manufacturing, quality control, and regulation. The issues of acceleration, product supply, manufacturing capacity, innovative technologies, high-throughput manufacturing, and rapid analytical testing are not new, but the pandemic has increased the urgency for the industry to make changes and accelerate pharmaceutical innovation. The conference will cover these topics from the perspectives of academics and regulators as they explore the theme of this year’s event – Biomanufacturing in the New Era.
As part of the agenda, we will host the following presentation in the Live Poster Lounge on Wednesday, September 15 at 10 a.m. CEST:
From Cell Culture to Sterility: Applications for Rapid Detection Across the Entire Biomanufacturing Process | Jon Kallay, Sr. Technology & Market Development Manager, Microbial Solutions
Whether you’re still in development or already manufacturing, our Microbial Solutions services provide state-of-the-art technology and expert regulatory advice that will help you anticipate challenges, avoid roadblocks, and make better decisions. Please reach out to us at [email protected] if you have any questions.